The purpose of the Increasing Transparency in Generic Drug Applications Act is to enhance the clarity and openness of the process for approving generic drugs. This legislation aims to ensure that applicants for generic drugs receive clear information about how their products compare to existing brand-name drugs, particularly regarding their inactive ingredients and overall formulation.